Ambulatory ICU Study for Medically and Socially Complex Patients (SUMMIT)

February 6, 2023 updated by: Brian L Chan, Oregon Health and Science University

Does a Clinic Based Complex Care Coordination Intervention Improve Patient Quality Outcomes in an Underserved Clinic Population? The Streamlined, Unified, Meaningfully Managed Interdisciplinary Team (SUMMIT) Ambulatory ICU Study

This is a prospective randomized wait-list control study to determine whether a stand-alone, co-located team of physician, mental health behaviorist, and care coordinators with decreased panel size (aka "intensive primary care") will reduce inpatient and emergency care utilization, inpatient costs of care, and improve patient activation and experience for medically and socially complex patients, compared to enhanced usual care at 6 and 12 months. Participants with multiple co-morbidities, and meet utilization criteria will have the opportunity to enroll; half the participants will start the intervention immediately, while half will continue enhanced usual care for 6 months before beginning the intervention.

Study Overview

Detailed Description

The goal of this study is to conduct an evaluation of an "Ambulatory-ICU" model of primary care for "high utilizer" patients with medical, behavioral, and social complexity. A small proportion of patients use > 50 % of healthcare resources. It is currently unknown what interventions can help reduce inappropriate utilization due to lack of studies with rigorous study design, particularly in patients with high rates of homelessness, mental illness and substance use. The use of high-risk teams for select patients is a promising model of primary care that removes barriers to accessing usual care services by centralizing medical and behavioral clinical services, promotes ability to outreach beyond the clinic, and promote continuity of care and trust-building between patient and provider teams.

This study will test the hypothesis that a stand-alone clinic based intervention of a multidisciplinary, co-located physician, mental health behaviorist, nursing, pharmacist, and care coordinators with reduced panel size, and focus on patient capacity building and decreasing treatment burden will improve health outcomes at 6 and 12 months in a low-income high utilizer population with history of homelessness.

Enhanced usual care comprises of care delivered at Old Town Clinic (OTC) a Federally Qualified Health Center (FQHC) that is modeled on the Patient Centered Medical Home (PCMH) model. Patients have a designated primary care physician and care team with access to chronic disease education, mental health, social work, and substance abuse programs through referral system. In addition, participants thought to have difficulty engaging in primary care have access to a Health Resilience Specialist, a community health worker intervention who conducts outreach and assists the patient in care navigation.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97209
        • Central City Concern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

• One or more of the following medical diagnoses:

  • congestive heart failure
  • uncontrolled diabetes
  • end stage liver disease
  • chronic kidney disease (stage III or higher)
  • chronic obstructive pulmonary disease (group C or D)
  • chronic or severe soft tissue infections or ulcers
  • osteomyelitis
  • failure to thrive

And/OR:

• One or more of the following behavioral health diagnoses:

  • psychotic disorder
  • mood disorder
  • post-traumatic stress disorder
  • active substance use disorder

And/OR

• One or more of the following utilization patterns:

  • 1+ medical hospital admission in prior 6 months
  • frequent missed appointments (cancel or no-show for >5 primary care or specialty appointments in previous 12 months

Exclusion Criteria:

  • Non-English speaking
  • Patients on hospice, nursing home, rehabilitation, or other institutional or long term care facility
  • Inability to consent (as demonstrated by teach back of the consent process)
  • Diagnosis of metastatic brain cancer
  • Inability to participate in follow up phone due to aphasia, severe hearing impairment, or lack of access to telephone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SUMMIT intervention group
This group will transfer primary care to the SUMMIT team, which consists of: 1 primary care provider, 1 clinical nurse, 1 team manager, 2 care-coordinators, 2 behavioralists, 1 clinical pharmacist. This interdisciplinary team will have reduced patient panel load and increased flexibility in time and scheduling in order to foster trust and continuity with the patient with a goal of decreasing treatment burden and increasing patient capacity. Specific activities that participants will receive include: 1) comprehensive initial intake and care plan development that incorporates patient goal setting; 2) flexible scheduling of appointments with outreach; 3) transitional care coordination; 4) built-in behavioural counselling and case management; 5) regular review of care plan by team members.
See description in experimental arm.
Other Names:
  • intensive primary care team, complex care team
ACTIVE_COMPARATOR: enhanced usual care group
This group will continue to receive primary care as usual for 6 months. This includes care provided by the patient's existing primary care provider, access to a clinic's Health Resilience outreach worker, mental health consultation, and other services provided by usual care. After 6 months, the baseline survey is administered and the participant will transfer care to the intervention as described above in the SUMMIT intervention group.
See description in active comparator arm.
Other Names:
  • usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medical Hospitalizations
Time Frame: 6 months
Administrative data will be used to determine hospital admissions
6 months
Emergency Care visits
Time Frame: 6 months
Administrative data will be used to determine Emergency Department (ED) visits over study period
6 months
Primary care utilization
Time Frame: 6 months
Clinic administrative data will be used to determine primary care visits over study period
6 months
Patient Activation Measure (PAM)
Time Frame: 6 months
Study survey of the PAM measure is a validated instrument to assess patient self-efficacy
6 months
Patient Experience (ambulatory CAHPS)
Time Frame: 6 months
Study survey of patient reported assessment of patient experience
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Life Chaos
Time Frame: 6 months
Study survey of a validated instrument to assess self-reported life chaos
6 months
inpatient costs of care
Time Frame: 6 months
claims data for patients will be used to determine costs of inpatient care
6 months
inpatient average length of stay
Time Frame: 6 months
Administrative data will be used to determine average length of stay each hospitalization
6 months
Functional status using Short Form (SF)-12 survey
Time Frame: 6 months
patient reported survey of functional status
6 months
number of falls
Time Frame: 6 months
Study survey with question asking how many falls over the last 6 months
6 months
Edmonton Symptom Assessment Scale (ESAS) palliative measure
Time Frame: 6 months
Study survey with one question from the ESAS questionaire
6 months
Medical Hospitalizations
Time Frame: 12 months
Administrative data will be used to determine hospital admissions
12 months
Emergency Care visits
Time Frame: 12 months
Administrative data will be used to determine ED visits
12 months
Patient Activation Measure (PAM)
Time Frame: 12 months
Study survey of the PAM measure is a validated instrument to assess patient self-efficacy
12 months
Primary care utilization
Time Frame: 12 months
Clinic administrative data will be used to determine primary care visits over study period
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brian Chan, MD, Assistant Professor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 27, 2016

Primary Completion (ACTUAL)

August 28, 2020

Study Completion (ACTUAL)

December 30, 2021

Study Registration Dates

First Submitted

June 28, 2017

First Submitted That Met QC Criteria

July 19, 2017

First Posted (ACTUAL)

July 21, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 15285

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

upon request, the investigators can share de-identified, cleaned IPD for other researchers.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Health Care

Clinical Trials on SUMMIT intervention

3
Subscribe